Korean J Physiol Pharmacol.  2000 Feb;4(1):73-79.

Effect of sedative dose of propofol on neuronal damage after transient forebrain ischemia in Mongolian gerbils

Affiliations
  • 1Department of Pharmacology, Keimyung University School of Medicine, 194 Dongsan-dong, Taegu, South Korea.

Abstract

This study investigated whether propofol, an intravenous, non-barbiturate anesthetic, could reduce brain damage following global forebrain ischemia. Transient global ischemia was induced in gerbils by occlusion of bilateral carotid arteries for 3 min. Propofol (50 mg/kg) was administered intraperitoneally 30 min before, immediately after, and at 1 h, 2 h, 6 h after occlusion. Thereafter, propofol was administered twice daily for three days. Treated animals were processed in parallel with ischemic animals receiving 10% intralipid as a vehicle or with sham-operated controls. In histologic findings, counts of viable neurons were made in the pyramidal cell layer of the hippocampal CA1 area 4 days after ischemia. The number of viable neurons in the pyramidal cell layer of CA1 area was similar in animals treated with a vehicle or a subanesthetic dose of propofol. In terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) assay, semiquantitative analysis of dark-brown neuronal cells was made in the hippocampal CA1 area. There was no significant difference in the degree of TUNEL staining in the hippocampal CA1 area between vehicle-treated and propofol-treated animals. These results show that subanesthetic dose of propofol does not reduce delayed neuronal cell death following transient global ischemia in Mongolian gerbils.


MeSH Terms

Animals
Brain
Carotid Arteries
Cell Death
DNA Nucleotidylexotransferase
Gerbillinae*
In Situ Nick-End Labeling
Ischemia*
Neurons*
Propofol*
Prosencephalon*
Pyramidal Cells
DNA Nucleotidylexotransferase
Propofol
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr